The improvement in liver fibrosis (F3/4 to F1/2) after DAAs treatment was associated with higher baseline values of HDL and platelet count and lower baseline values of insulin and HOMA-IR, despite the overall assessment of these parameters comparing before and after treatment and comparing F1/2 with F3/4 before treatment revealing no significant changes. Here, INS is linked to Hepatic fibrosis.